Dec 18, 2020

Featuring interviews with Drs Maha Hussain, Ursula Matulonis, Phillip A Phillip and Hope S Rugo on the following topics:

• PARP inhibitors for breast cancer — Hope S Rugo, MD (0:00)
• Case: A woman in her early 60s with dermatomyositis is diagnosed with ER-positive breast cancer and ovarian cancer and a germline BRCA1...

Dec 8, 2020

This program includes faculty lectures on PARP inhibitors by Drs Kathleen Moore on ovarian cancer, Joyce O’Shaughnessy on breast cancer, Michael J Pishvaian on metastatic pancreatic cancer and Emmanuel S Antonarakis on prostate cancer. Access NCPD information and select publications...

Dec 8, 2020

Special nursing program focused on PARP inhibitors. This program includes case discussions from the practices of Deborah Wright, MSN, APRN, CNS, Jamie Carroll, APRN, MSN, CNP, Tammy Triglianos, RN, MS, ANP-BC, AOCNP and Erika Meneely, APRN, BC. Access NCPD information and select publications here.

• Case: A woman in her...

Oct 20, 2020

Proceedings from the third in a 3-part webinar series. Featuring perspectives from Drs Marcia S Brose, Andrew McKenzie and Milan Radovich, including on the following topics:

• Part 1: Molecular Tumor Board
• • Introduction (00:00)
  • Case: A woman in her late 70s with ER-positive, HER2-negative metastatic breast cancer (ESR,...

Oct 13, 2020

Proceedings from the second in a 3-part webinar series. Featuring perspectives from Drs Alexander E Drilon, Andrew McKenzie and Milan Radovich, including on the following topics:

• Part 1: Case Presentations
• • Introduction (00:00)
  • Case: A woman in her early 70s with metastatic adenocarcinoma of the lung (ERBB2, PALB2)...